Mubadala Bio’s IDS to handle UAE portfolio of over 20 GSK medicines
The alliance was signed at the Abu Dhabi Future Health Summit.
- Publish date: 2026-10-21
- Category: Standards & Policy
- Original source: Emirates News Agency (WAM)
- Reading time: 1 min read
Mubadala Bio’s IDS and GSK signed an alliance at the Abu Dhabi Future Health Summit. IDS will manage UAE sales, marketing, distribution and promotion for GSK General Medicines, covering a portfolio of more than 20 medicines.